Han Shen

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Immune Response

Extracellular Matrix

Top Venues

Cancer biology & medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Xueqing Kong, Jinyi Zhang, Shuwei Chen, Xianyang Wang, Qing Xi, Han Shen, Rongxin Zhang
Immune checkpoint inhibitors: breakthroughs in cancer treatment. Cancer biology & medicine (2024)
Xueqing Kong, Jinyi Zhang, Shuwei Chen, Xianyang Wang, Qing Xi, Han Shen, Rongxin Zhang
Immune checkpoint inhibitors: breakthroughs in cancer treatment. Cancer biology & medicine 21 (6) (2024)
Xueqing Kong, Jinyi Zhang, Shuwei Chen, Xianyang Wang, Qing Xi, Han Shen, Rongxin Zhang
Immune checkpoint inhibitors: breakthroughs in cancer treatment. Cancer biology & medicine 21 (6) (2024)
Biaojie Huang, Qiurui Chen, Zhiyun Ye, Lin Zeng, Cuibing Huang, Yuting Xie, Rongxin Zhang, Han Shen
Construction of a Matrix Cancer-Associated Fibroblast Signature Gene-Based Risk Prognostic Signature for Directing Immunotherapy in Patients with Breast Cancer Using Single-Cell Analysis and Machine Learning. International journal of molecular sciences 24 (17) (2023)
Qiurui Chen, Xuejia Wang, Yichen Zheng, Ting Ye, Jing Liu, Jin-Quan Wang, Wen-Feng Zhang, Feng-Lin Wu, Huaben Bo, Hongwei Shao, Rongxin Zhang, Han Shen
Cancer-associated fibroblasts contribute to the immunosuppressive landscape and influence the efficacy of the combination therapy of PD-1 inhibitors and antiangiogenic agents in hepatocellular carcinoma. Cancer (2023)